Form 4: Biodesix Chairman Converts Restricted Stock Units, Updates Beneficial Ownership

John Patience, Chairman and Director of Biodesix Inc., reported the conversion of restricted stock units into common stock, updating his direct and indirect beneficial ownership.

Summary

• John Patience, a Director, 10% Owner, and Chairman of Biodesix Inc. (BDSX), filed a Form 4 reporting changes in his beneficial ownership.
• On June 30, 2025, Mr. Patience acquired 22,874 shares of Common Stock through the conversion of Restricted Stock Units (RSUs).
• Following this transaction, his direct beneficial ownership of Common Stock is 407,486 shares.
• Indirect beneficial ownership includes 2,153,298 shares held by Patience Enterprises LP, 4,829,611 shares by John Patience Living Trust dated 7/23/1993, and 52,988 shares by his spouse.
• Mr. Patience disclaims beneficial ownership of securities held by Patience Enterprises LP except to the extent of his pecuniary interest.
• He is the sole general partner of Patience Enterprises LP and the sole trustee of John Patience Living Trust (July 23, 1993).
• Remaining Restricted Stock Units total 45,747, which are scheduled to vest in three substantially equal installments on June 30, September 30, and December 31, 2025, contingent on his continued service.

Sentiment

Score: 5

Explanation: The document reports a routine insider transaction (RSU conversion) which is a standard part of executive compensation. It does not indicate any significant positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

Remaining Restricted Stock Units (RSUs) totaling 45,747 are set to vest in three substantially equal installments on June 30, September 30, and December 31, 2025, subject to John Patience's continued service with Biodesix Inc.

Industry Context

This filing is a routine disclosure of insider stock transactions, common across all publicly traded companies, providing transparency into executive and director holdings and compensation structures.

Related Party Transactions

• John Patience's indirect beneficial ownership includes shares held by Patience Enterprises LP (where he is the sole general partner), John Patience Living Trust (July 23, 1993) (where he is the sole trustee), and shares held by his spouse.

Stakeholder Impact

• Shareholders gain transparency into the equity holdings and compensation structure of a key executive and director, John Patience.

Next Steps

• Future vesting of remaining Restricted Stock Units on September 30, 2025, and December 31, 2025.

Key Dates

Keywords

Biodesix, BDSX, Form 4, Insider Trading, John Patience, Restricted Stock Units, RSU, Beneficial Ownership, Corporate Governance